NovaBay Pharmaceuticals, Inc. — Director's Dealing 2014

Feb 1, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovaBay Pharmaceuticals, Inc. (NBY)
CIK: 0001389545
Period of Report: 2014-01-30

Reporting Person: McPherson T. Alex (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-30	Option (right to buy)	$1.14	A	86528	Acquired	2024-01-30	Common Stock (86528)	Direct

Footnotes

F1: Granted pursuant to the 2007 Omnibus Incentive Plan and the 2014 Non-Employee Director Compensation Plan

F2: Stock Options will vest in 12 equal monthly installments, starting on the date of grant.